Bold Rx-To-OTC Switches On The Horizon? Naloxone, Perhaps
A regulatory framework is in place for additional Rx-to-OTC switches where appropriate, including the opioid overdose antidote naloxone. It is up to sponsors to work with the FDA to deliver more switched products.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Joshua Cohen, Contributor Source Type: news
More News: Overdose | Pharmaceuticals